XOMAP Q1 2022 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+728.5% YoY

Gross Profit

$3M98.2% margin

Operating Income

-$2M-66.5% margin

Net Income

-$2M-73.4% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

-91.4%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$978,000

Balance Sheet

Total Assets

$159M

Total Liabilities

$19M

Stockholders' Equity

$140M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$375,000	+728.5%
Gross Profit	$3M	$314,000	+871.7%
Operating Income	-$2M	-$6M	+67.9%
Net Income	-$2M	-$7M	+69.1%